Filing Details
- Accession Number:
- 0001562180-24-000784
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-29 17:51:57
- Reporting Period:
- 2024-01-25
- Accepted Time:
- 2024-01-29 17:51:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314102 | Eyepoint Pharmaceuticals Inc. | EYPT | Laboratory Analytical Instruments (3826) | 262774444 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1574261 | A. Dario Paggiarino | C/O Eyepoint Pharmaceuticals, Inc. 480 Pleasant Street Watertown MA 02472 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-25 | 300 | $13.13 | 36,805 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-01-25 | 300 | $12.90 | 37,105 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-25 | 300 | $25.00 | 36,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-01-25 | 300 | $25.00 | 36,505 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-25 | 300 | $0.00 | 300 | $13.13 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-25 | 300 | $0.00 | 300 | $12.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,304 | 2031-02-09 | No | 4 | M | Direct | |
| 16,635 | 2030-02-28 | No | 4 | M | Direct |
Footnotes
- The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years.
- The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020
Billionaire Hedge Funds
